Expert consensus on the clinical use of cladribine tablets for treating relapsing multiple sclerosis in the asia-pacific region

Authors:

Abstract
No abstract available
Funding Information
  • Merck KGaA
  • Merck Healthcare KGaA (10.13039/100,009,945)

This publication has 41 references indexed in Scilit: